Heart Test Laboratories, Inc. (NASDAQ:HSCS – Free Report) – Investment analysts at Ascendiant Capital Markets issued their Q3 2025 earnings estimates for Heart Test Laboratories in a research note issued on Monday, January 20th. Ascendiant Capital Markets analyst L. Ward anticipates that the company will post earnings per share of ($2.41) for the quarter. The consensus estimate for Heart Test Laboratories’ current full-year earnings is ($9.82) per share. Ascendiant Capital Markets also issued estimates for Heart Test Laboratories’ Q4 2025 earnings at ($2.46) EPS, FY2025 earnings at ($9.82) EPS, Q1 2026 earnings at ($2.18) EPS, Q2 2026 earnings at ($2.11) EPS, Q3 2026 earnings at ($2.13) EPS, Q4 2026 earnings at ($1.93) EPS and FY2026 earnings at ($8.35) EPS.
Separately, Maxim Group reiterated a “buy” rating and issued a $12.00 price target on shares of Heart Test Laboratories in a research note on Wednesday, December 18th.
Heart Test Laboratories Trading Up 0.6 %
NASDAQ HSCS opened at $3.49 on Wednesday. Heart Test Laboratories has a 12 month low of $2.36 and a 12 month high of $18.50. The company has a current ratio of 1.72, a quick ratio of 1.52 and a debt-to-equity ratio of 0.01. The stock has a 50 day moving average of $3.43 and a 200-day moving average of $3.51. The company has a market cap of $3.42 million, a PE ratio of -0.44 and a beta of 2.90.
Heart Test Laboratories (NASDAQ:HSCS – Get Free Report) last announced its quarterly earnings data on Monday, December 16th. The company reported ($2.27) earnings per share for the quarter, beating the consensus estimate of ($2.30) by $0.03. During the same period in the prior year, the firm posted ($15.92) earnings per share.
Heart Test Laboratories Company Profile
Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.
Featured Articles
- Five stocks we like better than Heart Test Laboratories
- Upcoming IPO Stock Lockup Period, Explained
- SAP’s Strong Momentum: A Bullish Setup for Investors
- How to Read Stock Charts for Beginners
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.